Dr Reddy's Laboratories investigates complaint alleging violation of US laws

A reputed independent US law firm has been appointed the investigator to the complaint.

Nov 19, 2020 10:11 IST India Infoline News Service

Dr Reddys Laboratories
Dr Reddy's Laboratories Limited, India’s second-largest pharmaceutical company in terms of revenue, intimated the exchanges regarding an investigation into a complaint.

Filed by an anonymous entity, the complaint in question alleges that healthcare professionals in Ukraine and potentially in other countries were provided with improper benefits in violation of US laws.

The company informed that it has commenced investigation into the same. A reputed independent US law firm has been appointed the investigator to the complaint.

Dr Reddys was is trading at Rs4,741.20 per piece up by Rs37.95 or 0.81% from its previous closing of Rs4,703.25 on the BSE, at around 10.41am. 

The scrip opened at Rs4,690 and has touched the day's high and low of Rs4,812.20 and Rs4,660.05 respectively.

Related Story